{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:48:39Z","timestamp":1792687719912,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.jaip.2016.11.007","type":"journal-article","created":{"date-parts":[[2016,12,22]],"date-time":"2016-12-22T21:17:00Z","timestamp":1482441420000},"page":"1015-1024.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":101,"title":["Identifying Risk of Future Asthma Attacks Using UK Medical Record Data: A Respiratory Effectiveness Group Initiative"],"prefix":"10.1016","volume":"5","author":[{"given":"John D.","family":"Blakey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Pizzichini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todor A.","family":"Popov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borislav D.","family":"Dimitrov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirkje S.","family":"Postma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn K.","family":"Josephs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Papi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjan","family":"Kerkhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth V.","family":"Hillyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Chisholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2016.11.007_bib1","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1164\/rccm.200711-1754OC","article-title":"Cluster analysis and clinical asthma phenotypes","volume":"178","author":"Haldar","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2016.11.007_bib2","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.jaci.2010.07.019","article-title":"Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma","volume":"126","author":"Bousquet","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.11.007_bib3","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1136\/thx.2006.066407","article-title":"50 years of asthma: UK trends from 1955 to 2004","volume":"62","author":"Anderson","year":"2007","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2016.11.007_bib4","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1183\/09031936.00165106","article-title":"Severe exacerbations predict excess lung function decline in asthma","volume":"30","author":"Bai","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2016.11.007_bib5","doi-asserted-by":"crossref","first-page":"250","DOI":"10.4104\/pcrj.2011.00058","article-title":"Asthma and psychological dysfunction","volume":"20","author":"Thomas","year":"2011","journal-title":"Prim Care Respir J"},{"key":"10.1016\/j.jaip.2016.11.007_bib6","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-2466-9-24","article-title":"Economic burden of asthma: a systematic review","volume":"9","author":"Bahadori","year":"2009","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.jaip.2016.11.007_bib7","doi-asserted-by":"crossref","first-page":"e356","DOI":"10.1136\/bmj.e356","article-title":"25 year trends in first time hospitalisation for acute myocardial infarction, subsequent short and long term mortality, and the prognostic impact of sex and comorbidity: a Danish nationwide cohort study","volume":"344","author":"Schmidt","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.jaip.2016.11.007_bib8","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1365-2222.2007.02683.x","article-title":"Near-fatal asthma phenotype in the ENFUMOSA cohort","volume":"37","author":"Romagnoli","year":"2007","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2016.11.007_bib9","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1183\/09031936.06.00145105","article-title":"TENOR risk score predicts healthcare in adults with severe or difficult-to-treat asthma","volume":"28","author":"Miller","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2016.11.007_bib10","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1183\/09031936.00170110","article-title":"Different inflammatory phenotypes in adults and children with acute asthma","volume":"38","author":"Wang","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2016.11.007_bib11","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0140-6736(12)60988-X","article-title":"Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial","volume":"380","author":"Pavord","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2016.11.007_bib12","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1370\/afm.854","article-title":"Absolute cardiovascular disease risk and shared decision making in primary care: a randomized controlled trial","volume":"6","author":"Krones","year":"2008","journal-title":"Ann Fam Med"},{"key":"10.1016\/j.jaip.2016.11.007_bib13","unstructured":"Global Initiative for Asthma. GINA report, Global Strategy for Asthma Management and Prevention. 2015. Available from: http:\/\/www.ginasthma.org\/. Accessed May 4,\u00a02016."},{"key":"10.1016\/j.jaip.2016.11.007_bib14","unstructured":"British Thoracic Society, Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma: a national clinical guideline (SIGN 141). October 2014. Available from: http:\/\/www.sign.ac.uk\/guidelines\/fulltext\/141\/. Accessed May 4,\u00a02016."},{"key":"10.1016\/j.jaip.2016.11.007_bib15","doi-asserted-by":"crossref","first-page":"A31","DOI":"10.1136\/thoraxjnl-2012-202678.068","article-title":"A\u00a0systematic review of factors associated with future asthma attacks to inform a risk assessment questionnaire","volume":"67","author":"Blakey","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2016.11.007_bib16","unstructured":"The Triple A Test: Avoid Asthma Attacks (Asthma UK Risk Test). Asthma UK. Available from: https:\/\/www.asthma.org.uk\/advice\/manage-your-asthma\/risk-test\/. Accessed February 8,\u00a02016."},{"key":"10.1016\/j.jaip.2016.11.007_bib17","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1136\/thoraxjnl-2012-202093","article-title":"The At-Risk Registers in Severe Asthma (ARRISA) study: a cluster-randomised controlled trial examining effectiveness and costs in primary care","volume":"67","author":"Smith","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2016.11.007_bib18","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.jaci.2014.08.015","article-title":"Development and validation of a novel risk score for asthma exacerbations: the risk score for exacerbations","volume":"135","author":"Bateman","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.11.007_bib19","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/thx.2006.066837","article-title":"External validity of randomised controlled trials in asthma: to whom do the results of the trials apply?","volume":"62","author":"Travers","year":"2007","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2016.11.007_bib20","unstructured":"Optimum Patient Care Research Database (OPCRD). Available from: http:\/\/www.optimumpatientcare.org\/Html_Docs\/OPCRD.html. Accessed June 4,\u00a02016."},{"key":"10.1016\/j.jaip.2016.11.007_bib21","unstructured":"Respiratory Effectiveness Group (REG). Available from: http:\/\/www.effectivenessevaluation.org\/. Accessed June 4,\u00a02016."},{"key":"10.1016\/j.jaip.2016.11.007_bib22","unstructured":"NHS Employers. Quality and Outcomes Framework. Available from: http:\/\/www.nhsemployers.org\/your-workforce\/primary-care-contacts\/general-medical-services\/quality-and-outcomes-framework. Accessed June 4,\u00a02016."},{"key":"10.1016\/j.jaip.2016.11.007_bib23","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A\u00a0new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J\u00a0Chronic Dis"},{"key":"10.1016\/j.jaip.2016.11.007_bib24","unstructured":"Understanding HSMRs: a toolkit on hospital standardised mortality ratios, version 9. Available from: http:\/\/www.drfoster.com\/dr-foster-learning-labs-modules\/. Accessed June 4,\u00a02016."},{"key":"10.1016\/j.jaip.2016.11.007_bib25","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1164\/rccm.200801-060ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice","volume":"180","author":"Reddel","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2016.11.007_bib26","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3109\/02770901003605332","article-title":"Subacute lack of asthma control and acute asthma exacerbation history as predictors of subsequent acute asthma exacerbations: evidence from managed care data","volume":"47","author":"O'Connor","year":"2010","journal-title":"J\u00a0Asthma"},{"key":"10.1016\/j.jaip.2016.11.007_bib27","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1378\/chest.05-3084","article-title":"Assessing future need for acute care in adult asthmatics: the Profile of Asthma Risk Study: a prospective health maintenance organization-based study","volume":"132","author":"Osborne","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2016.11.007_bib28","unstructured":"Joint British Societies (JBS) for the prevention of cardiovascular disease. JBS3 cardiovascular risk assessment calculator. Available from: http:\/\/www.jbs3risk.com\/JBS3Risk.swf. Accessed June 4,\u00a02016."},{"key":"10.1016\/j.jaip.2016.11.007_bib29","unstructured":"Royal College of Physicians. Why asthma still kills: the National Review of Asthma Deaths (NRAD) Confidential Enquiry Report. May 2014. Available from: https:\/\/www.rcplondon.ac.uk\/sites\/default\/files\/why-asthma-still-kills-full-report.pdf. Accessed June 4,\u00a02016."},{"key":"10.1016\/j.jaip.2016.11.007_bib30","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/cea.12334","article-title":"Defining and managing risk in asthma","volume":"44","author":"Blakey","year":"2014","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2016.11.007_bib31","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jaci.2010.06.030","article-title":"Analyses of shared genetic factors between asthma and obesity in children","volume":"126","author":"Melen","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.11.007_bib32","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1164\/rccm.201203-0573OC","article-title":"Obesity and asthma: an inflammatory disease of adipose tissue not the airway","volume":"186","author":"Sideleva","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2016.11.007_bib33","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jaci.2015.11.036","article-title":"IL-4 promotes asymmetric dimethylarginine accumulation, oxo-nitrative stress, and hypoxic response-induced mitochondrial loss in airway epithelial cells","volume":"138","author":"Pattnaik","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.11.007_bib34","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S2213-2600(15)00367-7","article-title":"Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study","volume":"3","author":"Price","year":"2015","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2016.11.007_bib35","first-page":"1","article-title":"Predicting frequent asthma exacerbations using blood eosinophil count and other patient data routinely available in clinical practice","volume":"9","author":"Price","year":"2016","journal-title":"J\u00a0Asthma Allergy"},{"key":"10.1016\/j.jaip.2016.11.007_bib36","first-page":"CD011032","article-title":"Intermittent inhaled corticosteroid therapy versus placebo for persistent asthma in children and adults","volume":"7","author":"Chong","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaip.2016.11.007_bib37","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1183\/09031936.00075614","article-title":"Medication adherence and the risk of severe asthma exacerbations: a systematic review","volume":"45","author":"Engelkes","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2016.11.007_bib38","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.jaci.2011.09.011","article-title":"Quantifying the proportion of severe asthma exacerbations attributable to inhaled corticosteroid nonadherence","volume":"128","author":"Williams","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.11.007_bib39","doi-asserted-by":"crossref","first-page":"283","DOI":"10.4104\/pcrj.2012.00057","article-title":"A\u00a0cross-sectional study of patterns of airway dysfunction, symptoms and morbidity in primary care asthma","volume":"21","author":"Shaw","year":"2012","journal-title":"Prim Care Respir J"},{"key":"10.1016\/j.jaip.2016.11.007_bib40","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1186\/1471-2458-12-329","article-title":"The impact of the Quality and Outcomes Framework (QOF) on the recording of smoking targets in primary care medical records: cross-sectional analyses from The Health Improvement Network (THIN) database","volume":"12","author":"Taggar","year":"2012","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jaip.2016.11.007_bib41","doi-asserted-by":"crossref","first-page":"e005540","DOI":"10.1136\/bmjopen-2014-005540","article-title":"Validation of chronic obstructive pulmonary disease recording in the Clinical Practice Research Datalink (CPRD-GOLD)","volume":"4","author":"Quint","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.jaip.2016.11.007_bib42","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0140-6736(97)04248-7","article-title":"The UK General Practice Research Database","volume":"350","author":"Walley","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2016.11.007_bib43","doi-asserted-by":"crossref","first-page":"b81","DOI":"10.1136\/bmj.b81","article-title":"Use of primary care electronic medical record database in drug efficacy research on cardiovascular outcomes: comparison of database and randomised controlled trial findings","volume":"338","author":"Tannen","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jaip.2016.11.007_bibE1","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1513\/AnnalsATS.201309-300RM","article-title":"Quality standards for real-world research: focus on observational database studies of comparative effectiveness","volume":"11","author":"Roche","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jaip.2016.11.007_bibE2","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2016.11.007_bibE3","unstructured":"Electronic Register of Studies, European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP). Available from: http:\/\/www.encepp.eu\/encepp\/studiesDatabase.jsp. Accessed June 4,\u00a02016."},{"key":"10.1016\/j.jaip.2016.11.007_bibE4","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A\u00a0new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J\u00a0Chronic Dis"},{"key":"10.1016\/j.jaip.2016.11.007_bibE5","unstructured":"Understanding HSMRs: a toolkit on hospital standardised mortality ratios, version 9. Available from: http:\/\/www.drfoster.com\/dr-foster-learning-labs-modules\/. Accessed June 1,\u00a02016."},{"key":"10.1016\/j.jaip.2016.11.007_bibE6","unstructured":"British Thoracic Society, Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma: a national clinical guideline (SIGN 141). October 2014. Available from: http:\/\/www.sign.ac.uk\/guidelines\/fulltext\/141\/. Accessed June 1,\u00a02016."},{"key":"10.1016\/j.jaip.2016.11.007_bibE7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3132\/pcrj.2008.00045","article-title":"Assessing asthma control in routine clinical practice: use of the Royal\u00a0College of Physicians \u20183 questions\u2019","volume":"18","author":"Thomas","year":"2009","journal-title":"Prim Care Respir J"},{"key":"10.1016\/j.jaip.2016.11.007_bibE8","doi-asserted-by":"crossref","first-page":"288","DOI":"10.4104\/pcrj.2012.00052","article-title":"Clinical implications of the Royal College of Physicians three questions in routine asthma care: a real-life validation study","volume":"21","author":"Pinnock","year":"2012","journal-title":"Prim Care Respir J"},{"key":"10.1016\/j.jaip.2016.11.007_bibE9","unstructured":"GINA report, Global Strategy for Asthma Management and Prevention. Global Initiative for Asthma. Available from: http:\/\/www.ginasthma.org\/. Accessed May 4, 2016."}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219816305645?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219816305645?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:11:54Z","timestamp":1761973914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219816305645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S2213219816305645"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2016.11.007","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identifying Risk of Future Asthma Attacks Using UK Medical Record Data: A Respiratory Effectiveness Group Initiative","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2016.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}